Hypopigmented T-cell dyscrasia evolving to hypopigmented mycosis fungoides during etanercept therapy.
Chuang
Gary S
GS
Wasserman
Daniel I
DI
Byers
H Randolph
HR
Demierre
Marie-France
MF
D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D044383:Black People; D000068800:Etanercept; D005260:Female; D006801:Humans; D017496:Hypopigmentation / Q000209:etiology* / Q000473:pathology; D007074:Immunoglobulin G / Q000009:adverse effects*; D016410:Lymphoma, T-Cell, Cutaneous / Q000150:complications*; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000209:etiology* / Q000473:pathology; D018124:Receptors, Tumor Necrosis Factor; D012878:Skin Neoplasms / Q000150:complications* / Q000473:pathology
D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept